Recent Posts
- HealthInvest June 2026: A Look Inside Australia’s Healthcare Innovations
- HealthInvest Returns for 2026: Meet the Companies Shaping Australian Life Sciences
- Lifesaving Capital: How impact investing is shaping the future of biotech
- Investor Relations: the quiet advantage powering ASX microcaps
- HealthInvest Sydney: Life Sciences in the Investor Spotlight
Archives
How useful is independent research? Heard of MiFID II?
In this episode of Swings & Roundabouts, Marc Kennis of TMT Analytics and Stuart Roberts of NDF Research explore the wide-sweeping implications of MiFID II, particularly for company research.
June 7th, 2017
by
IR Dept
Read More
- 1
